Validation of Patient-reported Outcomes Measures for the Assessment of Gastroesophageal Reflux Disease (GERD) Symptoms

Clinical trial NCT00703534 · COMPLETED

Trial details

NCT number: NCT00703534
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

GERD Acid Reflux Disease Heartburn Regurgitation

Start date: 2008-05-01
Primary completion: 2009-01-01
Enrollment: 478

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.